Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 65Neoplasms 31Small Cell Lung Carcinoma 26Carcinoma, Hepatocellular 24Melanoma 23Colorectal Neoplasms 23Triple Negative Breast Neoplasms 20Carcinoma, Renal Cell 20Carcinoma, Transitional Cell 19Breast Neoplasms 18Neoplasm Metastasis 14Urinary Bladder Neoplasms 13Stomach Neoplasms 12Uterine Cervical Neoplasms 11Solid Tumors 11Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 8Lymphoma 7Lung Neoplasms 7Lymphoma, Non-Hodgkin 6Head and Neck Neoplasms 6Esophageal Neoplasms 6Pancreatic Neoplasms 5Liver Neoplasms 5Carcinoma, Merkel Cell 5Advanced Solid Tumor 5Solid Tumor 4Prostatic Neoplasms 4Leukemia, Myeloid, Acute 4Kidney Neoplasms 4

Interventions

atezolizumab 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × SCLC,Extensive Stage × atezolizumab × Clear all
NCT05595460 2026-04-13

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

RayzeBio, Inc.

Phase 1 Active not recruiting
21 enrolled
Thoracic

SCLC,Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡